Previous studies have shown that natural compounds such as Torilin can effectively inhibit endothelial cell proliferation and lumen formation by downregulating VEGF and insulin-like growth factor-II (IGF-II) expression in hepatoblastoma cells, resulting in strong antiangiogenic effects in animal studies (Kim M. S. et al., 2000). This evidence concerns the gene IGF2 and hepatoblastoma.